Document ID: chunk:federal_register_of_legislation:F2025C00189:reg:10:p1
Version: federal_register_of_legislation:F2025C00189
Segment Type: reg
Provision Reference: reg 10 (pt 1/3)
Character Range: 49638–52231

10  Exportation of goods specified in Schedule 8 (drugs)
 (1) The exportation from Australia of a Schedule 8 drug is prohibited:
 (a) unless:
 (i) the drug is exported from Australia by a licensed exporter; and
 (ii) the Secretary or an authorised person has, by an instrument in writing that is in force, granted permission for the licensed exporter to export the drug to a specified country; and
 (iii) the drug is exported from Australia within 3 months after the Secretary or an authorised person granted the permission or within any further period allowed from time to time by the Secretary or an authorised person and specified in the permission; and
 (iv) the drug is consigned to the country to which the Secretary or an authorised person has, by the instrument, granted the licensed exporter permission to export the drug; and
 (v) the licensed exporter, if asked by the Collector, produces the permission to the Collector; or
 (b) unless the drug is exported from Australia by a person on board a ship or aircraft, if the drug:
 (i) is not a drug listed in Schedule IV to the Single Convention; and
 (ii) is required for the medical treatment of the person or of another person under the care of the person; and
 (iii) was prescribed by a medical practitioner for that treatment; and
 (iv) was supplied to the person in accordance with the prescription of the medical practitioner mentioned in subparagraph (iii); or
 (c) unless the drug is exported from Australia by a person on board a ship or aircraft, if the drug:
 (i) is not a drug listed in Schedule IV to the Single Convention; and
 (ii) is required for the medical treatment of the person or of another person under the care of the person; and
 (iii) is included in Schedule 2 or Schedule 3 to the current Poisons Standard within the meaning of section 52A of the Therapeutic Goods Act 1989; and
 (iv) is being exported in an amount that does not exceed:
 (A) if the drug is a divided dosage product (including tablets and capsules) and pseudoephedrine is the sole active ingredient—30 dosage units; or
 (B) if the drug is a divided dosage product (including tablets and capsules) and it contains pseudoephedrine in combination with other active ingredients—50 dosage units; or
 (C) in any other case—3 months supply of the recommended daily dosage of the drug; or
 (d) unless the drug is exported from Australia by a person on board a ship or aircraft, if the drug:
 (i) is not a drug listed in Schedule IV to the Single Convention; and
 (ii) is required for the medical treatment of an animal that is being exported and is